Key points
- Law 491 of 2025 reserves filler injection to accredited dermatologists and plastic surgeons, and sets its highest fines for injecting without MINSA authorization [1][2].
- In Sonora, Mexico, 8 people died in 2026 after “vitamin drips.” Cofepris points to bacterial contamination [7][8].
- In Venezuela, an outbreak after mesotherapy affected 68 patients of the same practitioner and product [11].
- In 2026 INVIMA flagged tirzepatide sold “for aesthetic use” on Facebook [6].
US status (October 2026): See the peptide status tracker.
What happened in Panama, and why US clinics should care
The recurring failure in Latin American aesthetic and drip medicine is contamination in the supply and preparation chain, and that risk does not stop at a border. Panama answered with a law that narrows who may inject. If your menu includes mesotherapy, IV drips or injectables, the outbreaks behind the law are the part to study.
Law 491 of 2025 narrows who may inject fillers
On October 17, 2025 Panama enacted the law regulating filler and modeling substances. According to TVN and Telemetro, only “qualified physicians specialized in Dermatology or Plastic Surgery, accredited by the Technical Health Council” may apply them [1][2]. Consent must include “possible complications, adverse effects and risks associated with the procedure” [2]. Fines rise in tiers, with the maximum “for those who apply them without authorization from the Ministry of Health” [1]. MINSA must issue an official list of permitted substances, updated every 90 days, and the State must care for victims, including “ASIA syndrome” [1].
The bill was partially vetoed by the Executive in December 2024. According to Panamá América, MINSA’s view then was that “the only substances that should be used are those with sanitary registration” [3].
Open question. We could not access the Official Gazette text. So we have not confirmed the article numbers or whether hyaluronic acid falls within the definition of “filler substances.” What is cited comes from TVN and Telemetro [1][2].
Panama’s own cases set the stage
In 2017 MINSA closed the Acqua Viva clinic after a patient died following a “rejuvenating vitamin treatment.” The judicial inspection found “expired medicines without sanitary registration,” and the self-styled doctor advertised stem cells for Parkinson’s, Alzheimer’s and diabetes [4]. In 2018 surgeons warned that biopolymers might be offered in beauty clinics under other names. One surgeon called them “a time bomb” [5]. For the US side of stem cell marketing, see exosomes and stem cell marketing.
The region has drips, clandestine clinics and aesthetic tirzepatide
- Sonora, Mexico (2026): 8 deaths after “vitamin drips” prepared individually. According to Publimetro, Cofepris’s main preliminary hypothesis is that “the drips may have been contaminated with bacteria.” As of that report, the accused doctor was still a fugitive [7][8].
- Bogotá (2026): after a patient’s death, authorities closed at least 11 clandestine clinics, with “operating rooms hidden in houses and residential apartments,” and the city health department reported 282 complaints about these services between January 2025 and May 2026 [9].
- Colombia (2026): INVIMA flagged tirzepatide “advertised and sold in Colombia for aesthetic use” on Facebook, noting that “it is a medicine and not a product intended for aesthetic use” [6].
- Colombia, Law 2316 of 2023: injecting non-permitted modeling substances is a crime. For a health professional, the sentence is 96 to 180 months in prison [10].
- 8: deaths from “vitamin drips” in Sonora, 2026 [8]
- 68: patients in a mycobacterial outbreak after mesotherapy (Venezuela) [11]
- 90 days: the update cycle for MINSA’s list of permitted filler substances [1]
Mycobacteria are the infectious risk that keeps recurring
Nontuberculous mycobacterial infections after aesthetic injections appear again and again in Latin America:
- Caracas: 49 infections after mesotherapy, 81.6% confirmed as mycobacteria (M. abscessus, M. fortuitum), with treatment lasting 3 to 18 months. Two products were contaminated [12].
- Barinas, Venezuela: at least 68 patients of the same practitioner and product. According to the authors, it was the largest mesotherapy-associated outbreak described at the time, likely due to a contaminated injectable product [11].
- Buenos Aires: 28 of 169 mesotherapy patients (17%) had lesions from an organism compatible with M. immunogenum. After the antiseptic solution in use was discarded, no further cases occurred [13].
- Trujillo, Peru (2025): 7 women after various aesthetic procedures (DMAE, bicarbonate, PRP or hyaluronidase infiltrations, tensor threads and surgeries). The authors note few cases have been reported in Latin America, suggesting underdiagnosis [14].
- Belo Horizonte (2024 outbreak, congress abstract published in 2026): 29 patients reported with rapidly growing mycobacterial infection after submental liposuction at a dental clinic. M. abscessus was isolated in all 13 analyzed [15].
We found no published outbreak in Panama. In the regional reports, the source usually lies in the chain: contaminated injectable products, antiseptics or biosafety failures [11][12][13][15].
What this means for your clinic
Every outbreak above traces to something you control: what goes into the syringe or bag, who prepared it, and what was used to prep the skin. Source injectables and drip components from licensed pharmacies, keep lot records, and treat antiseptic handling as part of your infection control protocol. For how MDside structures drip programs, see IV therapy, and for supplier checks, see peptide supplier diligence.
References
- TVN. Sancionan ley que regula tratamientos estéticos con biopolímeros y polímeros. 21 de octubre de 2025. Link
- Telemetro. Presidente Mulino sanciona ley que regula el uso y aplicación de relleno en tratamientos estéticos. 21 de octubre de 2025. Link
- Panamá América. Presidente objeta proyecto de ley sobre regulación de sustancias y rellenos modelantes. Diciembre de 2024. Link
- Panamá América. Insólito: supuesto médico se hacía selfies con sus pacientes. 5 de octubre de 2017. Link
- Panamá América. Biopolímeros podrían hallarse bajo otro nombre en estéticas de Panamá. 17 de mayo de 2018. Link
- INVIMA (Colombia). Alerta Sanitaria No. 95-2026: Tirzepatida inyectable 20 mg/mL. 21 de abril de 2026. Link
- Expansión Política. Lo que se sabe de las muertes en Sonora por aplicación de suero vitaminado. 5 de abril de 2026. Link
- Publimetro México. Cofepris revela posible causa de muertes por sueros vitaminados que dejaron ocho fallecidos. 9 de abril de 2026. Link
- Publimetro Colombia. Autoridades sellaron más de 10 clínicas estéticas clandestinas en Bogotá por necrosis y medicamentos vencidos. 9 de julio de 2026. Link
- República de Colombia. Ley 2316 de 17 de agosto de 2023 (normograma INVIMA). Link
- Da Mata Jardín O, et al. [Follow-up on an outbreak in Venezuela of soft-tissue infection due to Mycobacterium abscessus associated with Mesotherapy]. Enferm Infecc Microbiol Clin. 2010;28(9):596-601. PMID 20106554. Link
- Rivera-Olivero IA, et al. [Soft-tissue infections due to non-tuberculous mycobacteria following mesotherapy. What is the price of beauty]. Enferm Infecc Microbiol Clin. 2006;24(5):302-6. PMID 16762255. Link
- Del-Castillo M, et al. Mesotherapy-associated outbreak caused by Mycobacterium immunogenum. Emerg Infect Dis. 2009;15(2):357-359. PMID 19193300. Link
- Valverde-López J, Plasencia PR, Mariños-Malón AP. Nontuberculous mycobacterial infections after cosmetic procedures: a case series. JAAD Case Rep. 2025;63:28-33. PMID 40787051. Link
- Moura AP, et al. Outbreak of rapidly growing nontuberculous mycobacteria (NTM) infection after surgical aesthetic procedures in the city of Belo Horizonte/MG: a case series (congress abstract). Braz J Infect Dis. 2026;30(Supl 1):105759. Link
This is general information, not medical or legal advice. Rules vary by state and change. Confirm your own facts with counsel.